News
1d
India Today on MSNWhat is PET-CT Imaging? Know types, use and beyondPET-CT scans combine structural and functional imaging to detect diseases early. This technology improves diagnosis accuracy ...
5don MSN
Danielle Walker, 36, plans to undergo immunotherapy treatment in Germany which costs £35,000 a course :: The family has ...
Neuroendocrine cancer articles from across Nature Portfolio Neuroendocrine cancer (also known as NETs) is a cancer type that arises from cells of the neuroendocrine system (cells that release ...
Kim Kardashian posted an emotional tribute to Lindsay May Palevsky, who died in November 2024 following a years-long battle ...
Kim Kardashian penned a tribute to Lindsay May Palevsky, a core member of her 'Lifers' group of childhood friends who died of ...
Nuclidium has raised 79 million Swiss francs ($99 million) as the Swiss and German biotech looks to continue the clinical ...
Proceeds will fund further clinical development of the company’s true theranostic pipeline and expansion of the global production and manufacturing network for copper-based ...
5d
Zacks.com on MSNExelixis Surges 35.2% in Three Months: Buy or Sell the Stock?Exelixis EXEL has put up a stellar performance so far this year. Shares of the biotech company have rallied 35.2% in the past three months compared with the industry ’s growth of 11.8%. The stock has ...
Kim Kardashian has paid a heartfelt tribute to her childhood friend eight months after her death from a rare form of cancer in an emotional remembrance shared on what would have be ...
Dana-Farber experts report rising rates of colorectal, pancreatic, esophageal, and other less common GI cancers in people under 50 and point to ...
6d
News-Medical.Net on MSNNovel tool offers a glimpse into the black box of ALT in aggressive cancersEach time a cell divides, a small section of each chromosome's protective cap - the telomere - is worn away. Most cells use ...
Crinetics Pharmaceuticals Announces July 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on July 10, 2025, the Compensation Committee of the Board ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results